Glucagon-like peptide 1 receptor agonists appear to reduce the risk of age-related macular degeneration and primary open-angle glaucoma.

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Weight loss medications like Wegovy and Zepbound can be effective but may pose risks for older adults, including muscle loss and bone density decline.

Because obesity and obesity-related conditions have been linked to several types of cancer, doctors believe that these ...

I’ m trying to lose the 18 pounds I have gained since the pandemic. It has been hard enough that I’ m wondering about Ozempic. I’ m also hearing about people doing Ozempic microdosing.

Over the past few days, as the rest of the stock market melted down, a revolution has been quietly brewing in the market for ...

From going blind and suffering from life-long diarrhea to battling addiction and finding love, people who take Ozempic and other GLP-1 medications are seeing that the drugs are doing more than ...

Novo Nordisk’s semaglutide diabetes and weight loss drugs, Ozempic and Wegovy, are no longer officially in shortage in the US ...

Why some health groups are banding together to push for a range of obesity-care options in workplace-sponsored insurance.

A Columbia University dermatologist argues that physicians in her specialty should be on the lookout for metabolic syndrome ...

Roche is doubling down on competing for a slice of the rapidly growing GLP-1 pie. The Swiss pharma giant announced a deal worth up to $5.3 billion on Wednesday with Danish drugmaker Zealand Pharma to ...

The Outsourcing Facilities Association is appealing a ruling that rejected their request for an injunction against the FDA’s ...